title: Structure-activity relationship of acridine derivatives to amyloid aggregation of lysozyme.
abstract: BACKGROUND
  Amyloid-related diseases (such as Alzheimer's disease or diabetes type II) are associated with self-assembly of protein into amyloid aggregates.
  
  
  METHODS
  Spectroscopic and atomic force microscopy were used to determine the ability of acridines to affect amyloid aggregation of lysozyme.
  
  
  RESULTS
  We have studied the effect of acridine derivatives on the amyloid aggregation of lysozyme to investigate the acridine structure-activity relationship. The activity of the effective planar acridines was characterized by the half-maximum depolymerization concentration DC(50) and half-maximal inhibition concentration IC(50). For the most effective acridine derivatives we examined their interaction with DNA and their effect on cell viability in order to investigate their eventual influence on cells. We thus identified planar acridine derivatives with intensive anti-amyloid activity (IC(50) and DC(50) values in micromolar range), low cytotoxicity and weak ability to interfere with the processes in the cell.
  
  
  CONCLUSIONS
  Our findings indicate that both the planarity and the tautomerism of the 9-aminoacridine core together with the reactive nucleophilic thiosemicarbazide substitution play an important role in the anti-amyloid activities of studied derivatives.
  
  
  CONCLUSIONS
  The present findings favor the application of the selected active planar acridines in the treatment of amyloid-related diseases.
authors.affiliation: Department of Biophysics, Institute of Experimental Physics, Slovak Academy of Sciences, Kosice, Slovakia.
authors.forename: Andrea
authors.initials: A
authors.lastname: Antosova
authors.forename: Beatrice
authors.initials: B
authors.lastname: Chelli
authors.forename: Eva
authors.initials: E
authors.lastname: Bystrenova
authors.forename: Katarina
authors.initials: K
authors.lastname: Siposova
authors.forename: Francesco
authors.initials: F
authors.lastname: Valle
authors.forename: Jan
authors.initials: J
authors.lastname: Imrich
authors.forename: Maria
authors.initials: M
authors.lastname: Vilkova
authors.forename: Pavol
authors.initials: P
authors.lastname: Kristian
authors.forename: Fabio
authors.initials: F
authors.lastname: Biscarini
authors.forename: Zuzana
authors.initials: Z
authors.lastname: Gazova
mesh_terms: D000166:Acridines / Q000737:chemistry* / Q000494:pharmacology*; D000544:Alzheimer Disease / Q000188:drug therapy / Q000378:metabolism; D000682:Amyloid / Q000037:antagonists & inhibitors* / Q000378:metabolism*; D000818:Animals; D002460:Cell Line; D002470:Cell Survival / Q000187:drug effects; D002645:Chickens; D004247:DNA / Q000378:metabolism; D006801:Humans; D020128:Inhibitory Concentration 50; D009113:Muramidase / Q000378:metabolism*; D013329:Structure-Activity Relationship
chemical_list: D000166:Acridines; D000682:Amyloid; D004247:DNA; D009113:Muramidase